University Of California Los Angeles

The American College of Cardiology and the American Heart Association, in collaboration with the Heart Failure Society of America, released retired, revised and new measures for the 2011 Heart Failure Measure set.

John A. Glaspy, MD, MPH, has been named the inaugural Simms/Mann Family Foundation endowed chair in integrative oncology at University of California, Los Angeles.

American Association for Cancer Research today released its annual Cancer Progress Report, which outlines advances in treatment and prevention and describes how the COVID-19 pandemic has drastically altered cancer research and care.

The addition of spartalizumab to dabrafenib and trametinib failed to prolong PFS among patients with BRAF-mutated advanced melanoma, according to results from the randomized phase 3 COMBI-i trial presented at ESMO Virtual Congress 2020.

The European Society for Medical Oncology announced the recipients of this year’s ESMO Awards.

Icosapent ethyl as an adjunct to statin therapy significantly reduced multiple plaque components, including low-attenuation plaque, at 18 months, compared with placebo, according to final results of the EVAPORATE trial.

Cardiologists and clinicians do not often recognize the sex-specific CVD pathophysiology in women, especially when using imaging modalities to diagnose patients, according to a speaker.

Shorter door-to-needle times lowered all-cause mortality and all-cause readmission at 1 year in patients aged at least 65 years with acute ischemic stroke treated with tissue plasminogen activator, researchers found.

The Mayo Clinic in Rochester, Minnesota, has been named the No. 1 hospital in the United States for pulmonology and lung surgery by U.S. News & World Report, according to its 2020-2021 Best Hospital rankings.

As an oncologist who treats melanoma, Antoni Ribas, MD, PhD, typically views skin color from a strictly scientific perspective.